Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 11Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Solid Tumor 4Rectal Neoplasms 4Neoplasms 3Lymphoma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Tongue Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Thromboembolism 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Teratoma 1Spinal Cord Neoplasms 1Seminoma 1Sarcoma, Synovial 1

Interventions

pegfilgrastim 1X-Rays 1Radiotherapy, Conformal 1Radiotherapy 1Ifosfamide 1Glutamine 1Fluorodeoxyglucose F18 1Doxorubicin 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Liposarcoma × Fluorodeoxyglucose F18 × Clear all
NCT00346125 2022-12-15

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
70 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡